A study to find out more about biomarkers in kidney cancer

Cancer type:

Kidney cancer

Renal cell cancer

Status:

Results

Phase:

Other

In this study doctors wanted to develop tests for biomarkers that could help in the assessment and treatment of kidney cancer.

The study was open for people to join between 2011 and 2014. The team reported the results in 2018. There is a link to more information in the ‘Summary of results’ section below.

More about this trial

A biomarker is a substance in the body that doctors can measure. They are often proteins. They can help tell doctors how likely it is that a cancer is growing, or how well treatment is working.

In this study, doctors looked at blood and urine samples from:

people with kidney cancer
people with other medical conditions
people without cancer or other conditions (healthy volunteers)

They looked for differences in biomarkers between the groups. The aim was to find biomarkers that could lead to a test to help diagnose or treat kidney cancer in the future.

Summary of results

We aim to add a lay summary of results to all the studies on our database. Unfortunately we have not been able to include a summary for this one.

There is more information about the results in the link below.

Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT
Peter J Selby and others
NIHR Journals Library, June 2018. Programme Grants for Applied Research, No. 6.3.

Please note, the document we link to here is not in plain English. It has been written for healthcare professionals and researchers. But it does include a short plain English summary written by the research team.